Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €38.25 EUR
Change Today +0.35 / 0.92%
Volume 2.0K
CGM On Other Exchanges
EN Paris
As of 11:35 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

cegedim sa (CGM) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/21/15 - €42.99
52 Week Low
10/16/14 - €22.50
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CEGEDIM SA (CGM)

Related News

No related news articles were found.

cegedim sa (CGM) Related Businessweek News

View More BusinessWeek News

cegedim sa (CGM) Details

Cegedim SA designs, develops, implements, markets, and provides technology and services for the healthcare industry worldwide. It operates through Healthcare Professionals, Insurance and Services, and GERS and Reconciliation divisions. The Healthcare Professionals division offers software solutions for the electronic management of patient records and prescriptions to pharmacists, physicians, and healthcare and paramedical networks; and drug databases. It also provides installation, maintenance, hosting, training, and call center services related to its products; financing options for computer equipment and outfitting of pharmacies to pharmacists and healthcare professionals; and marketing and point-of-sale services to pharmacies. The Insurance and Services division offers computerization solutions for health insurers and mutual health insurers; healthcare and third-party payment flow management products; and management services. It also provides hosting services; outsourcing services, such as payroll and HR services; and electronic data exchange services. The GERS and Reconciliation segment offers sales statistics for GERS’s pharmaceutical products; and medical sample management services. The company was founded in 1969 and is headquartered in Boulogne-Billancourt, France. Cegedim SA is a subsidiary of FCB SAS.

3,366 Employees
Last Reported Date: 05/26/15
Founded in 1969

cegedim sa (CGM) Top Compensated Officers

Founder, Chairman, Chief Executive Officer, C...
Total Annual Compensation: €494.0K
Director, Member of Audit Committee, Member o...
Total Annual Compensation: €234.0K
Managing Director, Director and Member of Aud...
Total Annual Compensation: €446.6K
Compensation as of Fiscal Year 2014.

cegedim sa (CGM) Key Developments

Cegedim SA Reports Consolidated Revenue Results for the Second Quarter and First Half Ended June 30, 2015; Confirms Earnings Guidance for the Year 2015

Cegedim SA reported consolidated revenue results for the second quarter and first half ended June 30, 2015. For the quarter, the company reported revenue of EUR 124.8 million compared to EUR 125.2 million a year ago. For the first half, the company reported revenue of EUR 246.1 million compared to EUR 238.6 million a year ago. For the year 2015, the company confirmed its expectation of like-for-like revenue growth from continuing activities of 2.5% and underlying EBIT growth of 10%.

Cegedim SA, Q2 2015 Sales/ Trading Statement Call, Jul 28, 2015

Cegedim SA, Q2 2015 Sales/ Trading Statement Call, Jul 28, 2015

Cegedim SA Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Full Year of 2015

Cegedim SA reported consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported revenue of EUR 121,309,000 compared to EUR 113,370,000 a year ago. EBITDA was EUR 19,143,000 compared to EUR 13,613,000 a year ago. Operating income from recurring operations was EUR 6,826,000 compared to EUR 4,651,000 a year ago. Operating income was EUR 5,344,000 compared to EUR 4,038,000 a year ago. Net loss for the period from continuing operations was EUR 1,844,000 compared to EUR 6,125,000 a year ago. Consolidated loss for the period was EUR 51,000 compared to EUR 8,962,000 a year ago. Cash flow generated from operating activities after tax paid and change in working capital requirements was EUR 31,026,000 compared to EUR 28,409,000 a year ago. Acquisitions of intangible assets were EUR 14,215,000 compared to EUR 12,955,000 a year ago. Acquisitions of tangible assets were EUR 6,409,000 compared to EUR 5,441,000 a year ago. This relative stability in EBITDA was mainly due to the increase in self-financed contracts. It should be noted that over the duration of the contract, self-financed contracts have a higher positive impact on margins than do resold contracts. Net debt came to EUR 519.5 million at the end of March 31, 2015, up EUR 15.3 million compared with the end of 2014. Diluted loss per share was EUR 0.0 compared to EUR 0.6 a year ago. The company provided earnings guidance for the full year of 2015. For the period, the company expects consolidated revenue from continuing activities to grow by 2.5%, like for like. The company is raising its growth rate outlook for consolidated EBIT from continuing activities before special items from 5.0% to 10.0%.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CGM:FP €38.25 EUR +0.35

CGM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CompuGroup Medical AG €27.22 EUR -0.465
Nextedia €1.12 EUR -0.07
Oracle Corp $37.46 USD +0.64
View Industry Companies

Industry Analysis


Industry Average

Valuation CGM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.1x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CEGEDIM SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at